Description

Spegra Tablets contain a modern, fixed-dose combination of Dolutegravir (DTG), Emtricitabine (FTC), and Tenofovir Alafenamide (TAF)—three well-established antiretroviral agents used in comprehensive HIV care. This once-daily combination supports adherence to treatment and is dispensed only upon prescription from a licensed medical professional.

As a prescription antiretroviral medicine, Spegra requires proper evaluation, dosage planning, and monitoring by healthcare specialists. Patients should not alter the dosage or discontinue treatment without professional advice. The tablets must be stored properly as per packaging guidelines to ensure stability and effectiveness.

Important Note:
Spegra must not be used without medical supervision. Only a qualified doctor can determine patient suitability, dosage schedule, and duration. Follow all medical and regulatory guidelines when purchasing or handling prescription antiretroviral medicines.